[1]
“Does Fidaxomicin reduce Cure and Recurrence rates compared to Vancomycin in Clostridium Difficile Infection patients?: A Systematic Review and Meta-analysis”, GAIMS J MED SCI, vol. 2, no. 1 (Jan-Jun), pp. 30–35, Jun. 2022, Accessed: Oct. 25, 2025. [Online]. Available: http://gjms.gaims.ac.in/ojs/index.php/gjms/article/view/43